Atlas Trials

Trial Evaluating Paliperidone Extended-Release (ER) Tablets Versus Placebo on Sleep in Schizophrenia Patients

Clinical trial NCT00105326 · COMPLETED

Trial details

NCT number
NCT00105326
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
SchizophreniaInsomnia
Start date
2005-02-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.